Creso is a global operation perfectly positioned to seize market share in the industry through its highly experienced leadership, diverse geographical agility and strict adherence to pharmaceutical rigour.
Creso strives for the highest quality in its products, leveraging science and research in order to develop, register and commercialise innovative therapeutic approaches targeting the endocannabinoid system.
Through worldwide distribution rights and commercialisation partners, Creso is able to develop the most competitive pharmaceutical-grade nutraceuticals and medicinal cannabis products on the market today.
The nutraceutical and food supplement segments are the fastest growing untapped market segments for therapeutic products. The total global nutraceuticals market reached US$142.1 billion in 2011 and is expected to reach US$204.8 billion by 2017 (Transparency Market Research), spurred primarily by dietary supplements and bolstered by rising health concerns, the growth of certain demographics and the increasing consumer desire to lead a healthy life and avoid dependence on synthetic drugs.
Cannabinoid-based nutraceutical products could generate well over $1 billion annually before 2019 (Brightfield Report cited in Forbes). The rise of this trend has seen an emergence of multinational pharmaceutical and food companies enter the market, using Europe as a hub for commercial operations.
Creso sees Europe as the prime launching pad for its entry into the nutraceutical market. Successes in Europe should pave the way towards launches in other markets of interest, including Australia, the Middle East, the Gulf Region and Latin America.
The above image is a statement of current intentions as at Feb 28th 2018. As with any future forecast, intervening events and new circumstances (including the need to adapt to a changing competitive environment, and the level of demand for the Company’s products) have the potential to affect the manner in which the resources of the Company are ultimately applied. The Board reserves the right to alter the way the resources of the Company are applied (and therefore products developed) on this basis.
These videos are intended for investor use only. Any products discussed herein are intended to provide information for investment decisions only, and not for promotional activities directed towards public or health care professionals. There are risks and uncertainties inherent in any forward looking statements. These statements are provided here to allow investors the opportunity to understand management's beliefs and opinions in respect to the future.